Italy
Opocrin Group, with its slogan "Opocrin Group: Excellence needs passion", exemplifies a robust presence in the pharmaceutical sector with a particular focus on the research, development, production, and commercialization of active pharmaceutical ingredients and innovative therapeutic solutions. Established in 1964, this Italian-based company has carved a significant niche in the heparin derivatives market, establishing itself as a global market leader.
Operating within the Manufacturing, Pharmaceutical, and Marketing industries, Opocrin Group emphasizes innovation, competence, and dedication. The company's growth has been organically propelled without recent external investments, positioning it as a mature and stable entity within the competitive pharmaceutical landscape.
With a reported share capital of €3,000,000, Opocrin Group remains fundamentally committed to ethical practices and scientific empowerment to enhance human life globally. This steadfast dedication suggests potential for long-term value creation for investors seeking stable and ethically-driven investment opportunities.
